Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-10-23
1998-02-24
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544344, 562433, 562434, 552 8, 564218, 560 20, 560 21, C07D24138, C07D40112, C07D40512, A61K 31495
Patent
active
057212341
ABSTRACT:
Novel glutamate receptor antagonists represented by the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein
REFERENCES:
patent: 4889855 (1989-12-01), Jacobsen et al.
patent: 5081123 (1992-01-01), Honore et al.
patent: 5308845 (1994-05-01), Honore et al.
patent: 5389687 (1995-02-01), Schaus et al.
K. Lippert et al., Eur. J. Pharmacol. 253 (3), 207-13 (1994).
W. Loescher et al., Eur. J. Neurosci. 5(11), 1545-50 (1993).
J. Mosinger et al., Exp. Neurol. 113, 10-17 (1991).
C.F. Bigge and T.C. Malone, Curr. Opin. Ther. Pat., 951 (1993).
M. A. Rogawski, TiPS 14, 325 (1993).
H. Li and A.M. Buchan, J. Cerebr. Blood Flow Metab. 13, 933 (1993).
B. Nellgard and T. Wieloch, J. Cerebr. Blood Flow Metab. 12, 2 (1992).
R. Bullock et al., J. Cerebr. Blood Flow Metab. 14, 466 (1994).
D. Xue et al., J. Cerebr. Blood Flow Metab. 14, 251 (1994).
X.-J. Xu et al., J. Pharmacol. Exp. Ther. 267, 140 (1993).
T. Namba et al., Brain Res. 638, 36 (1994).
S. E. Browne and J. McCulloch, Brain Res. 641, 10 (1994).
S.I. Yamaguchi et al., Epilepsy Res. 15, 179 (1993).
S.E. Smith et al., Eur. J. Pharmacol. 201, 179 (1991).
T. Klockgether et al., Ann Neurol. 34 (4), 585-593 (1993).
P.T. Francis et al., J. Neurochem. 60 (5), 1589-1604 (1993).
S. Lipton, TINS 16 (12), 527-532 (1993).
S. Lipton et al., New Eng. J. Med. 330 (9), 613-622 (1994).
C.F. Bigge, Biochem Pharmacol. 45, 1547-1561 (1993).
A.M. Buchan et al., Neurosci. Lett (Ireland) 132 (2), 255-8 (1991).
L. Dalgaard et al., Drug Metabolism and Disposition 22 (2), 289-93 (1994).
Bigge Christopher Franklin
Retz Daniel Martin
Anderson Elizabeth M.
Berch Mark L.
Warner-Lambert & Company
LandOfFree
Glutamate receptor antagonists: fused cycloalkylouinoxalinedione does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glutamate receptor antagonists: fused cycloalkylouinoxalinedione, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutamate receptor antagonists: fused cycloalkylouinoxalinedione will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1875336